ConductScience.org, home

Paper20111963

68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.

Brom M and 4 others. Eur J Nucl Med Mol Imaging, 2010. Cited by 113 papers, by iCite.

Cite this record

ConductScience Library. 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET. Papers, record 20111963. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20111963

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
PubMed
Journal
Eur J Nucl Med Mol Imaging
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
113
iCite
Relative citation ratio, by iCite
3.6
iCite
Revised in PubMed
2022-03-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brom MMaarten
2Oyen WJWim J G
3Joosten LLieke
4Gotthardt MMartin
5Boerman OCOtto C

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
InsulinomaMajor topic
PeptidesMajor topic
Positron-Emission TomographyMajor topic
Amino Acid Sequence
Animals
Biological Transport
Cell Line, Tumor
Dose-Response Relationship, Drug
Female
Gallium Radioisotopes
Heterocyclic Compounds, 1-Ring
Inhibitory Concentration 50
Injections
Kinetics
Lysine
Mice
Molecular Sequence Data
Pentetic Acid
Rats

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AG030328NIA NIH HHSUnited StatesR01AG030328PubMed and NIH
1R01 AG 030328-01NIA NIH HHSUnited StatesR01AG030328PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19024313Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today).Gastroenterology1997https://conductscience.org/library/papers/9024313PubMed
217227804Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.J Clin Endocrinol Metab2007https://conductscience.org/library/papers/17227804PubMed
317225119Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?Eur J Nucl Med Mol Imaging2007https://conductscience.org/library/papers/17225119PubMed
410382845In vivo dynamic distribution of 131I-glucagon-like peptide-1 (7-36) amide in the rat studied by gamma camera.Nucl Med Biol1999https://conductscience.org/library/papers/10382845PubMed
517138746[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.J Nucl Med2006https://conductscience.org/library/papers/17138746PubMed
615763697Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours.Best Pract Res Clin Endocrinol Metab2005https://conductscience.org/library/papers/15763697PubMed
717575235[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.Clin Cancer Res2007https://conductscience.org/library/papers/17575235PubMed
818205253Occult sporadic insulinoma: localization and surgical strategy.World J Gastroenterol2008https://conductscience.org/library/papers/18205253PubMed
916930741A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents.Regul Pept2006https://conductscience.org/library/papers/16930741PubMed
1010774879Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use.Eur J Nucl Med2000https://conductscience.org/library/papers/10774879PubMed
1114499161Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.Mol Imaging Biol2003https://conductscience.org/library/papers/14499161PubMed
1217934729Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin.Eur J Nucl Med Mol Imaging2008https://conductscience.org/library/papers/17934729PubMed
1318703486Glucagon-like peptide 1-receptor scans to localize occult insulinomas.N Engl J Med2008https://conductscience.org/library/papers/18703486PubMed
141370150Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines.Endocrinology1992https://conductscience.org/library/papers/1370150PubMed
157905200[Receptor scintigraphy using 111In-pentetreotide in endocrine gastroenteropancreatic tumors].Nuklearmedizin1993https://conductscience.org/library/papers/7905200PubMed
168563978Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites.Eur J Neurosci1995https://conductscience.org/library/papers/8563978PubMed
177800858Use of 125I-[Y39]exendin-4 to characterize exendin receptors on dispersed pancreatic acini and gastric chief cells from guinea pig.Regul Pept1994https://conductscience.org/library/papers/7800858PubMed
1811976797Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results.Eur J Nucl Med Mol Imaging2002https://conductscience.org/library/papers/11976797PubMed
198404961Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.Eur J Nucl Med1993https://conductscience.org/library/papers/8404961PubMed
2017520251Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours.Eur J Nucl Med Mol Imaging2007https://conductscience.org/library/papers/17520251PubMed

See all 23 referencesDownload CSV of references

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.

PMIDTitleJournalYearIn PapersSource
42380410High-yield, standardised automated radiosynthesis process for routine clinical insulinoma PET with [⁶⁸Ga]Ga-NODAGA-exendin-4.EJNMMI Radiopharm Chem2026https://conductscience.org/library/papers/42380410PubMed
4122313868 Ga-NODAGA-EXENDIN-4 PET/CT in the Detection or the Exclusion of Occult Sporadic Insulinomas.Clin Nucl Med2025https://conductscience.org/library/papers/41223138PubMed
41088364Engineered GLP-1R-targeting nanoplatforms: multimodal therapeutics in human diseases.J Nanobiotechnology2025https://conductscience.org/library/papers/41088364PubMed
40796705[68Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinism.EJNMMI Res2025https://conductscience.org/library/papers/40796705PubMed
40591218212Pb in targeted radionuclide therapy: a review.EJNMMI Radiopharm Chem2025https://conductscience.org/library/papers/40591218PubMed
40281248GLP- 1R status using validated monoclonal antibody in 689 cases of neuroendocrine neoplasm and its correlation with somatostatin receptor scintigraphy, insulin production, and histological grades.Virchows Arch2025https://conductscience.org/library/papers/40281248PubMed
40145271Characterization of the Pancreatic Neuroendocrine Neoplasm Immune Microenvironment.Cancer Med2025https://conductscience.org/library/papers/40145271PubMed
38227104Characterization and comparison of insulinoma tumor model and pancreatic damage caused by the tumor, and identification of possible markers.Mol Biol Rep2024https://conductscience.org/library/papers/38227104PubMed
37780209Theranostic in GLP-1R molecular imaging: challenges and emerging opportunities.Front Mol Biosci2023https://conductscience.org/library/papers/37780209PubMed
34695532Translational challenges in pancreatic neuroendocrine tumor immunotherapy.Biochim Biophys Acta Rev Cancer2021https://conductscience.org/library/papers/34695532PubMed
34432147Small peptide-based GLP-1R ligands: an approach to reduce the kidney uptake of radiolabeled GLP-1R-targeting agents?EJNMMI Radiopharm Chem2021https://conductscience.org/library/papers/34432147PubMed
34248856Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34248856PubMed
3421567268Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism.J Nucl Med2022https://conductscience.org/library/papers/34215672PubMed
31951592Innovative imaging of insulinoma: the end of sampling? A review.Endocr Relat Cancer2020https://conductscience.org/library/papers/31951592PubMed
31924726Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW.J Nucl Med2020https://conductscience.org/library/papers/31924726PubMed
31903131Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics.Theranostics2020https://conductscience.org/library/papers/31903131PubMed
31394799A Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [18F]fluoride: Will [18F]AlF Replace 68Ga for Metal Chelate Labeling?Molecules2019https://conductscience.org/library/papers/31394799PubMed
31378283Molecular imaging of β-cells: diabetes and beyond.Adv Drug Deliv Rev2019https://conductscience.org/library/papers/31378283PubMed
31370679Noninvasive longitudinal quantification of β-cell mass with [111In]-labeled exendin-4.FASEB J2019https://conductscience.org/library/papers/31370679PubMed
31163066Increasing molar activity by HPLC purification improves 68Ga-DOTA-NAPamide tumor accumulation in a B16/F1 melanoma xenograft model.PLoS One2019https://conductscience.org/library/papers/31163066PubMed

See all 66 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740NCBI Gene
SSTR56755PubTator's text mininghttps://conductscience.org/library/genes/6755NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20111963

GET https://conductscience.org/api/papers/v1/20111963/references?page=2